Another Study Links Low Vitamin D To Cardiovascular Disease

0 Shares

John Cannell, M.D., has compiled information on two studies that seem to show that Vitamin D is the missing link in patients with cardiovascular disease.

Writing in his Vitamin D Council blog, Cannell looked at a study done by researchers at Hull York Medical School in England on two of the most commonly prescribed statin drugs: Lipitor (atorvastatin) and Zocor (simvastatin). Both lower cholesterol equally and both are used to prevent cardiovascular disease.

But a study shows that cardiovascular events are lower in patients on Lipitor than in patients on Zocor. The possible reason for these results is interesting. It’s not because Lipitor reduces oxidative stress and inflammation better than Zocor; they both do that equally well. But Lipitor raises Vitamin D levels more than Zocor does.

The authors wrote:

In conclusion, 25OHD concentrations are higher in patients when taking atorvastatin rather than simvastatin at doses that lead to equivalent reductions in LDL. The vitamin D rise is associated with significant improvements in markers of oxidative stress and inflammation suggesting this may be a mechanism by which atorvastatin, in particular, exerts its pleiotropic effects.

This seems to show that increasing vitamin D levels may help reduce cardiovascular stress. Adequate levels of vitamin D has been proven to help reduce the instance and severity of colds and the flu and to influence dozens of other conditions, including: cancer, heart disease, hypertension, obesity, diabetes types I and II, aging signs, osteoporosis, seizures, Alzheimer’s disease, dementia, schizophrenia, inflammation, inflammatory bowel disease, multiple sclerosis, infertility, depression and asthma.

Bob Livingston

founder of Personal Liberty Digest™, is an ultra-conservative American author and editor of The Bob Livingston Letter™, in circulation since 1969. Bob has devoted much of his life to research and the quest for truth on a variety of subjects. Bob specializes in health issues such as nutritional supplements and alternatives to drugs, as well as issues of privacy (both personal and financial), asset protection and the preservation of freedom.